[{"address1": "21 Hickory Drive", "address2": "Suite 500", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 819 2020", "website": "https://www.sionnatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; and SION-719 and SION-451, which are nucleotide-binding domain 1 stabilizers in Phase 1 trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Cloonan M.B.A.", "age": 53, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 784593, "exercisedValue": 0, "unexercisedValue": 1513609}, {"maxAge": 1, "name": "Ms. Elena H. Ridloff C.F.A.", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 647922, "exercisedValue": 0, "unexercisedValue": 473990}, {"maxAge": 1, "name": "Dr. Charlotte  McKee M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 647922, "exercisedValue": 0, "unexercisedValue": 432145}, {"maxAge": 1, "name": "Dr. Greg  Hurlbut Ph.D.", "title": "Co-Founder & Senior VP of Discovery Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark  Munson Ph.D.", "title": "Co-founder & Senior VP of Medicinal Chemistry", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Meghan  Bagshaw", "title": "Vice President of Programs, Portfolio & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andy  Chu", "title": "Vice President of Information & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Fitzpatrick J.D.", "age": 48, "title": "Chief Legal Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Vanya  Sagar", "age": 49, "title": "Chief People Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mara  Furlow M.S.", "title": "Senior Vice President of Global Regulatory Affairs & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 42.44, "open": 41.575, "dayLow": 40.705, "dayHigh": 42.94, "regularMarketPreviousClose": 42.44, "regularMarketOpen": 41.575, "regularMarketDayLow": 40.705, "regularMarketDayHigh": 42.94, "payoutRatio": 0.0, "forwardPE": -19.77409, "volume": 227303, "regularMarketVolume": 227303, "averageVolume": 285513, "averageVolume10days": 235420, "averageDailyVolume10Day": 235420, "bid": 41.33, "ask": 43.51, "bidSize": 2, "askSize": 2, "marketCap": 1886012544, "fiftyTwoWeekLow": 7.255, "fiftyTwoWeekHigh": 45.0, "allTimeHigh": 45.0, "allTimeLow": 7.255, "fiftyDayAverage": 41.3023, "twoHundredDayAverage": 26.712626, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1646651520, "profitMargins": 0.0, "floatShares": 15383990, "sharesOutstanding": 44628788, "sharesShort": 3053667, "sharesShortPriorMonth": 2876610, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0684, "heldPercentInsiders": 0.06929, "heldPercentInstitutions": 0.93899, "shortRatio": 8.65, "shortPercentOfFloat": 0.1141, "impliedSharesOutstanding": 44628788, "bookValue": 7.234, "priceToBook": 5.8418574, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -70676000, "trailingEps": -1.8, "forwardEps": -2.13714, "enterpriseToEbitda": -19.877, "52WeekChange": 0.6904, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 42.26, "targetHighPrice": 58.0, "targetLowPrice": 24.0, "targetMeanPrice": 44.85714, "targetMedianPrice": 45.0, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 248328992, "totalCashPerShare": 5.564, "ebitda": -82841000, "totalDebt": 8968000, "quickRatio": 25.209, "currentRatio": 25.614, "debtToEquity": 2.788, "returnOnAssets": -0.19454001, "returnOnEquity": -0.28075, "freeCashflow": -40376376, "operatingCashflow": -61452000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SION", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Sionna Therapeutics, Inc.", "longName": "Sionna Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1769807404, "regularMarketTime": 1769806801, "exchange": "NGM", "messageBoardId": "finmb_1779769831", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.42412892, "regularMarketPrice": 42.26, "epsTrailingTwelveMonths": -1.8, "epsForward": -2.13714, "epsCurrentYear": -2.03143, "priceEpsCurrentYear": -20.80308, "fiftyDayAverageChange": 0.9576988, "fiftyDayAverageChangePercent": 0.023187542, "twoHundredDayAverageChange": 15.547373, "twoHundredDayAverageChangePercent": 0.5820234, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2025-02-07", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1738938600000, "postMarketChangePercent": 0.0, "postMarketPrice": 42.26, "postMarketChange": 0.0, "regularMarketChange": -0.1800003, "regularMarketDayRange": "40.705 - 42.94", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 285513, "fiftyTwoWeekLowChange": 35.004997, "fiftyTwoWeekLowChangePercent": 4.824948, "fiftyTwoWeekRange": "7.255 - 45.0", "fiftyTwoWeekHighChange": -2.7400017, "fiftyTwoWeekHighChangePercent": -0.060888927, "fiftyTwoWeekChangePercent": 69.04, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": true, "displayName": "Sionna Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]